Patent · US Active

Method for administration

US11382892B2 · kind B2 · utility

0Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2019
Grant dateJul 12, 2022
Priority date—
Expiry dateAug 23, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/284
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided a new dosage regimen for Compound A which maximizes anti-tumor activity while maintaining acceptable toxicity levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.